Tower Research Capital LLC TRC Has $128,000 Position in Monsanto Company (MON)

Tower Research Capital LLC TRC increased its stake in shares of Monsanto Company (NYSE:MON) by 230.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,076 shares of the basic materials company’s stock after purchasing an additional 750 shares during the period. Tower Research Capital LLC TRC’s holdings in Monsanto were worth $128,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in Monsanto by 2.6% during the second quarter. Vanguard Group Inc. now owns 30,725,725 shares of the basic materials company’s stock worth $3,636,697,000 after acquiring an additional 784,418 shares in the last quarter. BlackRock Inc. lifted its holdings in Monsanto by 6.5% during the second quarter. BlackRock Inc. now owns 27,898,255 shares of the basic materials company’s stock worth $3,302,038,000 after acquiring an additional 1,705,439 shares in the last quarter. State Street Corp lifted its holdings in Monsanto by 0.6% during the second quarter. State Street Corp now owns 20,276,780 shares of the basic materials company’s stock worth $2,399,965,000 after acquiring an additional 122,814 shares in the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in Monsanto by 3.6% during the first quarter. Massachusetts Financial Services Co. MA now owns 14,299,502 shares of the basic materials company’s stock worth $1,618,703,000 after acquiring an additional 499,639 shares in the last quarter. Finally, Northern Trust Corp lifted its holdings in Monsanto by 0.7% during the second quarter. Northern Trust Corp now owns 7,092,929 shares of the basic materials company’s stock worth $839,519,000 after acquiring an additional 47,725 shares in the last quarter. 74.81% of the stock is owned by institutional investors and hedge funds.

In related news, VP Duraiswami Narain sold 2,860 shares of Monsanto stock in a transaction that occurred on Monday, September 25th. The shares were sold at an average price of $120.00, for a total value of $343,200.00. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, COO Brett D. Begemann sold 22,640 shares of Monsanto stock in a transaction that occurred on Monday, September 25th. The stock was sold at an average price of $120.03, for a total transaction of $2,717,479.20. Following the completion of the sale, the chief operating officer now directly owns 85,439 shares in the company, valued at approximately $10,255,243.17. The disclosure for this sale can be found here. In the last three months, insiders have sold 37,026 shares of company stock worth $4,440,341. Insiders own 0.79% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece of content was first published by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece of content on another site, it was stolen and reposted in violation of US & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/2957471/tower-research-capital-llc-trc-has-128000-position-in-monsanto-company-mon.html.

Monsanto Company (NYSE MON) traded up 2.07% during mid-day trading on Friday, reaching $122.39. The company had a trading volume of 2,898,500 shares. Monsanto Company has a one year low of $97.35 and a one year high of $122.79. The company has a market capitalization of $53.79 billion, a P/E ratio of 24.05 and a beta of 1.07. The stock has a 50 day moving average price of $118.57 and a 200 day moving average price of $117.22.

Monsanto (NYSE:MON) last announced its quarterly earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.41) by $0.61. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The business had revenue of $2.69 billion for the quarter, compared to analysts’ expectations of $2.51 billion. During the same quarter last year, the firm earned $0.07 EPS. The firm’s revenue for the quarter was up 4.8% compared to the same quarter last year. On average, equities analysts expect that Monsanto Company will post $5.70 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, October 6th will be given a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 1.80%. Monsanto’s dividend payout ratio is currently 42.27%.

MON has been the topic of several recent analyst reports. Vetr upgraded Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price on the stock in a report on Wednesday, July 12th. Piper Jaffray Companies set a $128.00 target price on Monsanto and gave the stock a “buy” rating in a report on Friday, August 11th. Zacks Investment Research upgraded Monsanto from a “hold” rating to a “buy” rating and set a $131.00 target price on the stock in a report on Tuesday, August 29th. BMO Capital Markets reiterated a “buy” rating and set a $128.00 target price on shares of Monsanto in a report on Friday, September 1st. Finally, Barclays PLC lifted their target price on Monsanto from $115.00 to $120.00 and gave the stock an “equal weight” rating in a report on Thursday, June 29th. Eleven equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $124.61.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.